Indiplon

Indiplon
Clinical data
Routes of; administration	Oral
ATC code	none;
Pharmacokinetic data
Elimination half-life	1.5–1.8 hours
Identifiers
	IUPAC name N-methyl-N-[3-[3-(thiophene-2-carbonyl); pyrazolo[5,1-b]pyrimidin-7-yl]phenyl]acetamide;
CAS Number	325715-02-4 ;
PubChem CID	6450813;
IUPHAR/BPS	4221;
ChemSpider	4953363 ;
UNII	8BT63DA42E;
KEGG	D02640 ;
ChEBI	CHEBI:188583;
ChEMBL	ChEMBL262075 ;
CompTox Dashboard (EPA)	DTXSID80186270 ;
ECHA InfoCard	100.133.676
Chemical and physical data
Formula	C20H16N4O2S
Molar mass	376.43 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(C1=CC=CS1)C2=C3N=CC=C(C4=CC(N(C)C(C)=O)=CC=C4)N3N=C2;
	InChI InChI=1S/C20H16N4O2S/c1-13(25)23(2)15-6-3-5-14(11-15)17-8-9-21-20-16(12-22-24(17)20)19(26)18-7-4-10-27-18/h3-12H,1-2H3 ; Key:CBIAWPMZSFFRGN-UHFFFAOYSA-N ;
	(what is this?) (verify)

Indiplon (INN and USAN) is an unmarketed nonbenzodiazepine, hypnotic sedative that was developed in two formulations—an immediate-release formulation for sleep onset, and a modified-release (also called controlled-release or extended-release) version for sleep maintenance.